In April, we added 128 citations in DIDB, including 67 in vitro (with 15 articles published in April 2025) and 61 in vivo articles (with 29 articles published in April 2025).
3 NDA approved in 2025, including gepotidacin (BLUJEPA), mirdametinib (GOMEKLI), and vimseltinib (ROMVIMZA) were also curated in DIDB.
You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.
As always, feel free to contact us if you have any questions or comments.